Our results show that MLK3 silencing can effectively improve cardiac function, reduce collagen deposition, ROS level, and ferroptosis in TAC mice at 8 weeks and can effectively inhibit the expression of JNK and p53 while increasing GPX4, xCT, and GSH levels. The gene discussed is GPX4; the disease is persistent truncus arteriosus.